Guide
Running an aesthetics clinic in Ireland: regulation and records
By Connor McAuley, Founder
Updated
Sources checked
Republic of Ireland aesthetics regulation for clinic owners: prescribing, fillers, professional scope, advertising and proposed reform. Sources checked 11 October 2026.
At a glance
In the Republic of Ireland, anti-wrinkle medicines and dermal fillers sit under different rules. Botulinum toxin is prescription-only; the Medical Council identifies doctors, dentists and registered nurses acting on their directions as the permitted administrators. Fillers are regulated as devices. Government policy to restrict filler administration is not evidence of a commenced practitioner licensing scheme. Check your professional scope and the actual products and services you offer.
General guidance. Check local requirements.
I have researched the rules across the UK nations and Ireland while building AesthetiClinic. For an Irish clinic, the first distinction to get right is between the medicine, the practitioner and the service: one answer does not cover all three.
This page is the regulation starting point for a clinic in the Republic of Ireland. Northern Ireland has a different system, covered in its own guide.
Start with the service you actually provide
| Clinic activity | First check | Evidence to keep |
|---|---|---|
| Anti-wrinkle treatment using a prescription medicine | HPRA product status and the practitioner’s professional regulator | Patient-specific prescription arrangements and who is responsible |
| Dermal fillers | Product documentation, professional scope and insurer cover | Supplier, product, batch and instructions for use |
| Employing or working with a nurse | NMBI registration, relevant competence and permitted scope | Registration checks, training and governance arrangements |
| Working with a doctor | Medical Council registration and prescribing/delegation duties | Prescriber identity and agreed responsibilities |
| Public marketing | HPRA medicine advertising rules | Dated wording and the approval record |
These are owner checks to organise before opening or changing your menu. They do not decide clinical suitability or authorise a treatment.
Anti-wrinkle medicines need a patient-specific arrangement
The Minister for Health’s January 2026 answer confirms that botulinum toxin is a prescription-only medicine under the Medicinal Products (Prescription and Control of Supply) Regulations. The Medical Council statement identifies registered doctors, registered dentists and registered nurses acting on a doctor or dentist’s directions as the permitted administrators.
The doctor’s duties go beyond writing a prescription. The Council’s position statement requires adequate knowledge of the patient, a clearly identified patient on the prescription and the doctor’s registration number. Delegating to a nurse requires confidence in the nurse’s relevant competence; the doctor retains professional responsibility for that delegation.
For the owner, record which prescriber is responsible, how the patient-specific prescription is obtained and how the directions remain available with the patient’s record. Do not treat a general stock arrangement or a training certificate as a replacement for those checks.
Nurses: registration is the beginning of the check
NMBI’s current guidance is addressed to Registered General Nurses. It requires relevant education, competence, authorisation, indemnity and governance, and says the guidance does not expand a nurse’s scope of practice.
It also says nurses cannot independently obtain or hold a supply of prescription-only medicine without a valid prescription specific to the individual patient. Nurse prescribing has conditions tied to employment by a health service provider, the setting and the usual course of that service. A prescribing qualification alone does not settle whether a particular independent-clinic arrangement meets those conditions.
A prescriber abroad needs a separate answer
The Medical Council’s November 2025 statement says doctors established elsewhere in the EU may lawfully prescribe certain medicines to patients in Ireland. NMBI’s guidance says the prescriber must be registered within this jurisdiction.
Those statements should not be turned into a blanket assurance that any remote or overseas arrangement is suitable for an Irish nurse-led clinic. Give the actual arrangement to NMBI, the Medical Council and your insurer and obtain a written position before relying on it.
Dermal fillers: check the product and the practitioner separately
The January ministerial answer describes dermal fillers as Class III medical devices under the EU Medical Device Regulation. It also explains that EU common specifications require the instructions for use to state that the products are not for people under 18 and should be administered by appropriately trained healthcare professionals. These are product-framework requirements, not an Irish practitioner licence.
The HPRA’s current filler guidance explains that it regulates devices and conducts market surveillance; it does not regulate filler administration, clinical qualifications or the licensing of the facilities using them. Its advice covers reputable sourcing, CE-marking documentation and reporting concerns.
That separation matters when a supplier describes a product as approved. A product document cannot establish your professional scope, your insurance cover or permission for your premises. Keep those checks distinct, with the product’s current instructions available to the practitioner.
What is changing in Ireland?
In the February 2026 answer, the Minister expected a Health Research Board report in the first half of the year. That was an expectation stated at that time, not evidence that the report was completed or published.
In the 28 April 2026 answer, the Minister said the Department of Health was exploring regulatory options and intended to publish the HPRA policy paper in the coming months. The HPRA’s current page still describes its submitted policy paper and work with the Department.
For this refresh, we checked those official records and later Oireachtas written-question entries through 11 October. We did not identify a later answer establishing commencement. The Department’s website was not accessible during the check, so the Department’s position here is sourced to its Minister’s official parliamentary answers. Confirm later publications directly before making an investment that depends on the future rules.
Advertising needs its own review
The Minister’s July 2026 answer confirms that public advertising of prescription medicines is prohibited, including on websites and social media. The HPRA’s explanation covers promotion by businesses offering services that may lead to prescription and supply.
Changing a medicine brand name to a treatment label is not a complete compliance test. Review the wording, imagery, offers and overall promotional context. Keep the dated copy you approved and arrange a medicines-advertising review when changing it.
Make a clinic evidence file you can retrieve
Organise the regulatory replies, practitioner registration checks, relevant training, insurance confirmation and product documents in a place the responsible people can retrieve. Give each a date and an owner for checking it again.
For patient records, NMBI’s guidance calls for accurate, detailed records that support continuity of care and accountability. A practical record structure links the reviewed history, consent, prescription where applicable, product traceability and completed treatment record. Our treatment record template supplies fields to adapt; it does not certify compliance.
Use the licensing-ready records checklist as an organisational starting point, then apply the Irish requirements you have confirmed. Do not import a UK licensing proposal or UK consumer-law answer into the Irish file as if it were Irish law.
This guide does not establish requirements for Irish laser/IPL services, premises, planning, waste or tax. Put those on the opening checklist and obtain the relevant authority’s answer for your actual service. A gap in this guide is not an exemption.
Compare the tools you need for documentation in our aesthetic clinic software overview. If you are choosing a system, use the best aesthetic clinic software buying guide to check workflows, costs and export terms.
FAQ
Can a nurse administer anti-wrinkle treatment in Ireland?
The Medical Council identifies registered nurses acting on a doctor or dentist’s directions as permitted administrators of botulinum toxin. NMBI’s guidance adds scope, competence, governance and patient-specific medicine requirements. Confirm the particular arrangement with NMBI and your insurer.
Does Ireland have a dermal filler licence for practitioners?
The sources checked distinguish the EU device framework from the Government’s proposed practitioner restrictions. We have not verified a commenced new filler practitioner licensing scheme. That does not establish that a particular person, product or clinic is authorised to provide treatment.
Do the UK prescribing rules apply in the Republic of Ireland?
Use the Irish rules and regulators. The five-nation chooser links the systems, but does not combine them into one legal regime.
Does clinic software make the clinic compliant?
Software can help keep records organised and retrievable. It cannot determine professional scope, approve prescribing arrangements or grant regulatory registration.
Your next step
Confirm the questions that apply to your service in writing, then use a records demo to inspect how the documents would sit together. Bring a blank example rather than patient information.